<?xml version="1.0" ?>
<text author="Dimitry  A. Chistiakov, Dmitry  A. Kashirskikh, Victoriya  A. Khotina, Andrey  V. Grechko, Alexander  N. Orekhov" dateCollected="2019-11-03" id="amalgum_academic_doc481" shortTile="immuneinflammatory" sourceURL="https://www.mdpi.com/2077-0383/8/11/1798/htm" speakerCount="0" speakerList="none" title="Immune-Inflammatory Responses in Atherosclerosis: The Role of Myeloid Cells" type="academic">
<head>
<s type="frag">
1.	LS	@ord@
Introduction	NN	introduction
</s>
</head>
<p>
<s type="decl">
Atherosclerosis	NNP	Atherosclerosis
is	VBZ	be
a	DT	a
common	JJ	common
pathology	NN	pathology
that	WDT	that
affects	VBZ	affect
large	JJ	large
and	CC	and
medium	JJ	medium
arteries	NNS	artery
leading	VBG	lead
to	TO	to
a	DT	a
variety	NN	variety
of	IN	of
cardiovascular	JJ	cardiovascular
events	NNS	event
that	WDT	that
can	MD	can
also	RB	also
be	VB	be
fatal	JJ	fatal
,	,	,
therefore	RB	therefore
representing	VBG	represent
a	DT	a
serious	JJ	serious
public	JJ	public
health	NN	health
problem	NN	problem
.	.	.
</s>
<s type="decl">
Atherosclerosis	NN	Atherosclerosis
is	VBZ	be
characterized	VBN	characterize
by	IN	by
progressive	JJ	progressive
lipid	NN	lipid
deposition	NN	deposition
in	IN	in
the	DT	the
arterial	JJ	arterial
wall	NN	wall
,	,	,
plaque	NN	plaque
induction	NN	induction
and	CC	and
possible	JJ	possible
further	JJR	further
progression	NN	progression
to	TO	to
the	DT	the
state	NN	state
of	IN	of
so-called	JJ	so-called
unstable	JJ	unstable
plaque	NN	plaque
.	.	.
</s>
<s type="decl">
Advanced	VBN	Advanced
plaques	NNS	plaque
usually	RB	usually
acquire	VBP	acquire
a	DT	a
fibrous	JJ	fibrous
cap	NN	cap
that	WDT	that
separates	VBZ	separate
the	DT	the
plaque	NN	plaque
from	IN	from
the	DT	the
surrounding	VBG	surround
milieu	NN	milieu
and	CC	and
plays	VBZ	play
a	DT	a
stabilizing	VBG	stabilize
role	NN	role
.	.	.
</s>
<s type="decl">
Destabilization	NN	destabilization
of	IN	of
plaques	NNS	plaque
leads	VBZ	lead
to	TO	to
their	PRP$	their
rupture	NN	rupture
with	IN	with
subsequent	JJ	subsequent
thrombus	NN	thrombus
formation	NN	formation
that	WDT	that
can	MD	can
lead	VB	lead
to	TO	to
dangerous	JJ	dangerous
events	NNS	event
such	JJ	such
as	IN	as
acute	JJ	acute
coronary	NN	coronary
syndrome	NN	syndrome
(	-LRB-	(
ACS	NNP	ACS
)	-RRB-	)
and	CC	and
stroke	NN	stroke
.	.	.
</s>
<s type="decl">
Advanced	VBN	Advanced
complicated	VBN	complicated
plaques	NNS	plaque
are	VBP	be
also	RB	also
characterized	VBN	characterize
by	IN	by
the	DT	the
formation	NN	formation
of	IN	of
the	DT	the
necrotic	JJ	necrotic
core	NN	core
,	,	,
pathological	JJ	pathological
vascular	JJ	vascular
remodeling	NN	remodel
,	,	,
plaque	NN	plaque
neovascularization	NN	neovascularization
and	CC	and
calcification	NN	calcification
.	.	.
</s>
</p>
<p>
<s type="decl">
Elevated	VBN	elevate
low-density	NN	low-density
lipoprotein	NN	lipoprotein
(	-LRB-	(
LDL	NNP	LDL
)	-RRB-	)
is	VBZ	be
known	VBN	know
to	TO	to
be	VB	be
associated	VBN	associate
with	IN	with
atherosclerosis	NN	atherosclerosis
and	CC	and
is	VBZ	be
identified	VBN	identify
as	IN	as
the	DT	the
major	JJ	major
source	NN	source
of	IN	of
lipids	NNS	lipid
accumulating	VBG	accumulate
in	IN	in
atherosclerotic	NN	atherosclerotic
plaques	NNS	plaque
.	.	.
</s>
<s type="decl">
Circulating	VBG	Circulating
modified	VBN	modify
LDL	NN	LDL
has	VBZ	have
increased	VBN	increase
atherogenicity	NN	atherogenicity
in	IN	in
comparison	NN	comparison
to	TO	to
native	JJ	native
LDL	NNP	LDL
.	.	.
</s>
<s type="decl">
Chemical	JJ	Chemical
modification	NN	modification
of	IN	of
LDL	NNP	LDL
likely	RB	likely
plays	VBZ	play
a	DT	a
prominent	JJ	prominent
role	NN	role
in	IN	in
atherosclerosis	NN	atherosclerosis
development	NN	development
.	.	.
</s>
<s type="decl">
Besides	RB	besides
elevated	VBN	elevate
LDL	NNP	LDL
,	,	,
chronic	JJ	chronic
inflammation	NN	inflammation
is	VBZ	be
now	RB	now
considered	VBN	consider
as	IN	as
another	DT	another
crucial	JJ	crucial
pro-atherogenic	JJ	pro-atherogenic
mechanism	NN	mechanism
that	WDT	that
can	MD	can
even	RB	even
precede	VB	precede
lipid	NN	lipid
entry	NN	entry
into	IN	into
the	DT	the
arterial	JJ	arterial
intima	NN	intima
.	.	.
</s>
</p>
<p>
<s type="decl">
It	PRP	it
has	VBZ	have
been	VBN	be
proposed	VBN	propose
that	IN	that
disturbances	NNS	disturbance
of	IN	of
hemodynamic	JJ	hemodynamic
forces	NNS	force
that	WDT	that
are	VBP	be
especially	RB	especially
likely	JJ	likely
to	TO	to
occur	VB	occur
at	IN	at
atheroprone	JJ	atheroprone
sites	NNS	site
of	IN	of
blood	NN	blood
vessels	NNS	vessel
,	,	,
such	JJ	such
as	IN	as
bends	NNS	bend
or	CC	or
bifurcations	NNS	bifurcation
,	,	,
can	MD	can
cause	VB	cause
local	JJ	local
activation	NN	activation
of	IN	of
endothelial	NN	endothelial
cells	NNS	cell
(	-LRB-	(
ECs	NNP	ECs
)	-RRB-	)
.	.	.
</s>
<s type="decl">
Consequently	RB	consequently
,	,	,
ECs	NNP	ECs
acquire	VBP	acquire
a	DT	a
pro-inflammatory	JJ	pro-inflammatory
phenotype	NN	phenotype
and	CC	and
start	VBP	start
expressing	VBG	express
different	JJ	different
pro-inflammatory	JJ	pro-inflammatory
molecules	NNS	molecule
,	,	,
such	JJ	such
as	IN	as
monocyte	NN	monocyte
chemotactic	NN	chemotactic
protein	NN	protein
1	CD	1
(	-LRB-	(
MCP1	NNP	MCP1
)	-RRB-	)
(	-LRB-	(
also	RB	also
known	VBN	know
as	IN	as
chemokine	NN	chemokine
(	-LRB-	(
C-C	NN	C-C
motif	NN	motif
)	-RRB-	)
ligand	NN	ligand
2	CD	2
;	:	;
CCL2	NNP	CCL2
)	-RRB-	)
,	,	,
intercellular	JJ	intercellular
adhesion	NN	adhesion
molecule	NN	molecule
1	CD	1
(	-LRB-	(
ICAM-1	NNP	ICAM-1
)	-RRB-	)
and	CC	and
vascular	JJ	vascular
cell	NN	cell
adhesion	NN	adhesion
molecule	NN	molecule
1	CD	1
(	-LRB-	(
VCAM-1	NNP	VCAM-1
)	-RRB-	)
,	,	,
all	DT	all
of	IN	of
which	WDT	which
attract	VBP	attract
monocytes	NNS	monocyte
to	TO	to
the	DT	the
activated	VBN	activate
endothelium	NN	endothelium
.	.	.
</s>
<s type="decl">
The	DT	the
imbalance	NN	imbalance
of	IN	of
monocyte/macrophage	NN	monocyte/macrophage
polarization	NN	polarization
towards	IN	towards
the	DT	the
preferential	JJ	preferential
pro-inflammatory	JJ	pro-inflammatory
phenotype	NN	phenotype
and	CC	and
a	DT	a
lack	NN	lack
of	IN	of
normal	JJ	normal
inflammation	NN	inflammation
resolution	NN	resolution
are	VBP	be
also	RB	also
present	JJ	present
in	IN	in
atherosclerosis	NN	atherosclerosis
.	.	.
</s>
<s type="decl">
Phagocytic	JJ	Phagocytic
macrophages	NNS	macrophage
actively	RB	actively
participate	VBP	participate
in	IN	in
lipid	NN	lipid
accumulation	NN	accumulation
by	IN	by
engulfing	VBG	engulf
lipid	NN	lipid
droplets	NNS	droplet
and	CC	and
give	VBP	give
rise	NN	rise
to	TO	to
foam	NN	foam
cells	NNS	cell
.	.	.
Dendritic	JJ	Dendritic
cells	NNS	cell
(	-LRB-	(
DCs	NNS	DC
)	-RRB-	)
contribute	VBP	contribute
to	TO	to
the	DT	the
local	JJ	local
inflammatory	JJ	inflammatory
response	NN	response
through	IN	through
antigen	NN	antigen
presentation	NN	presentation
and	CC	and
cytokine	NN	cytokine
signaling	VBG	signal
processes	NNS	process
.	.	.
</s>
<s type="decl">
If	IN	if
the	DT	the
inflammatory	JJ	inflammatory
process	NN	process
reaches	VBZ	reach
a	DT	a
resolution	NN	resolution
,	,	,
repair	VB	repair
processes	NNS	process
begin	VBP	begin
,	,	,
and	CC	and
the	DT	the
plaque	NN	plaque
can	MD	can
become	VB	become
stable	JJ	stable
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
failure	NN	failure
to	TO	to
resolve	VB	resolve
the	DT	the
inflammatory	JJ	inflammatory
response	NN	response
can	MD	can
result	VB	result
in	IN	in
the	DT	the
formation	NN	formation
of	IN	of
the	DT	the
most	RBS	most
dangerous	JJ	dangerous
unstable	JJ	unstable
plaque	NN	plaque
that	WDT	that
can	MD	can
cause	VB	cause
thrombosis	NN	thrombosis
.	.	.
</s>
</p>
<p>
<s type="decl">
Therefore	RB	therefore
,	,	,
a	DT	a
variety	NN	variety
of	IN	of
immune	NN	immune
cells	NNS	cell
are	VBP	be
involved	VBN	involve
in	IN	in
atherosclerosis	NN	atherosclerosis
initiation	NN	initiation
and	CC	and
progression	NN	progression
.	.	.
</s>
<s type="decl">
In	IN	in
this	DT	this
review	NN	review
,	,	,
we	PRP	we
consider	VBP	consider
main	JJ	main
subsets	NNS	subset
of	IN	of
pro-	JJ	pro-
and	CC	and
anti-inflammatory	JJ	anti-inflammatory
immune	NN	immune
cells	NNS	cell
of	IN	of
myeloid	NN	myeloid
origin	NN	origin
that	WDT	that
contribute	VBP	contribute
to	TO	to
atherogenesis	NN	atherogenesis
.	.	.
</s>
</p>
</text>
